Analysis of perioperative radiation therapy in the surgical treatment of primary and recurrent retroperitoneal sarcoma

Journal of Surgical Oncology

Volumn 112, Issue 4, 2015, Pages 352-358

  Lane, Whitney O ^a   Cramer, Christina K ^a   Nussbaum, Daniel P ^a   Speicher, Paul J ^a   Gulack, Brian C ^a   Czito, Brian G ^a   Kirsch, David G ^a   Tyler, Douglas S ^a   Blazer, Dan G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

radiotherapy; retroperitonealsarcoma; surgery; survival analysis

Indexed keywords

ACUTE TOXICITY; ADULT; ANGIOSARCOMA; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CHONDROSARCOMA; DEATH; DEDIFFERENTIATED LIPOSARCOMA; FEMALE; FOLLICULAR DENDRITIC CELL SARCOMA; FOLLOW UP; HEMANGIOPERICYTOMA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROPERITONEAL SARCOMA; RETROPERITONEAL TUMOR; RETROSPECTIVE STUDY; SPINDLE CELL SARCOMA; SYNOVIAL SARCOMA; ADJUVANT THERAPY; AGED; CANCER GRADING; CLINICAL TRIAL; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; RETROPERITONEAL NEOPLASMS; SARCOMA; SURVIVAL RATE; TUMOR RECURRENCE;

AGED; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PERIOPERATIVE CARE; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROPERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES; SARCOMA; SURVIVAL RATE;

EID: 84942296733     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23996     Document Type: Article

References (35)

1. Burningham Z, Hashibe M, Spector L, et al.,: The epidemiology of sarcoma. Clin Sarcoma Res 2012; 2: 14.
2. Clark MA, Fisher C, Judson I, et al.,: Soft-tissue sarcomas in adults. N Engl J Med 2005; 353: 701-711.
3. Lewis JJ, Leung D, Woodruff JM, et al.,: Retroperitoneal soft-tissue sarcoma: Analysis of 500 patients treated and followed at a single institution. Ann Surg 1998; 228: 355-365.
4. Brennan MF, Antonescu CR, Moraco N, et al.,: Lessons learned from the study of 10,000 patients with soft tissue sarcoma. Ann Surg 2014; 260: 416-421. discussion 421-2.
5. Bonvalot S, Rivoire M, Castaing M, et al.,: Primary retroperitoneal sarcomas: A multivariate analysis of surgical factors associated with local control. J Clin Oncol 2009; 27: 31-37.
6. Gronchi A, Casali PG, Fiore M, et al.,: Retroperitoneal soft tissue sarcomas: Patterns of recurrence in 167 patients treated at a single institution. Cancer 2004; 100: 2448-2455.
7. Gronchi A, Miceli R, Colombo C, et al.,: Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas. Ann Oncol 2012; 23: 1067-1073.
8. Brennan MF,: Lessons learned from the study of soft tissue sarcoma. Int J Surg 2013; 11: S8-10.
9. Pawlik TM, Pisters PW, Mikula L, et al.,: Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma. Ann Surg Oncol 2006; 13: 508-517.
10. Ferrario T, Karakousis CP,: Retroperitoneal sarcomas: Grade and survival. Arch Surg 2003; 138: 248-251.
11. Pawlik TM, Ahuja N, Herman JM,: The role of radiation in retroperitoneal sarcomas: A surgical perspective. Curr Opin Oncol 2007; 19: 359-366.
12. Zlotecki RA, Katz TS, Morris CG, et al.,: Adjuvant radiation therapy for resectable retroperitoneal soft tissue sarcoma: The University of Florida experience. Am J Clin Oncol 2005; 28: 310-316.
13. Nussbaum DP, Speicher PJ, Gulack BC, et al.,: Long-term oncologic outcomes after neoadjuvant radiation therapy for retroperitoneal sarcomas. Ann Surg 2014; 262: 163-170.
14. Pisters PW,: Retroperitoneal sarcomas-an SOS to colleagues in Europe. Ann Surg Oncol 2007; 14: 1787-1789.
15. Ballo MT, Zagars GK, Pollock RE, et al.,: Retroperitoneal soft tissue sarcoma: An analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys 2007; 67: 158-163.
16. Gieschen HL, Spiro IJ, Suit HD, et al.,: Long-term results of intraoperative electron beam radiotherapy for primary and recurrent retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys 2001; 50: 127-131.
17. Heslin MJ, Lewis JJ, Nadler E, et al.,: Prognostic factors associated with long-term survival for retroperitoneal sarcoma: Implications for management. J Clin Oncol 1997; 15: 2832-2839.
18. Kilkenny JW, 3rd, Bland K I, Copeland E M, 3rd,: Retroperitoneal sarcoma: The University of Florida experience. J Am Coll Surg 1996; 182: 329-339.
19. Bremjit PJ, Jones RL, Chai X, et al.,: A contemporary large single-institution evaluation of resected retroperitoneal sarcoma. Ann Surg Oncol 2014; 21: 2150-2158.
20. Kelly KJ, Yoon SS, Kuk D, et al.,: Comparison of perioperative radiation therapy and surgery versus surgery alone in 204 patients with primary retroperitoneal sarcoma: A retrospective 2-institution study. Ann Surg 2015; 262: 156-162.
21. Guillou L, Coindre JM, Bonichon F, et al.,: Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol 1997; 15: 350-362.
22. Gronchi A, Miceli R, Shurell E, et al.,: Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets. J Clin Oncol 2013; 31: 1649-1655.
23. von Mehren M, Randall RL, Benjamin RS, et al.,: Soft tissue sarcoma, version 2.2014. J Natl Compr Canc Netw 2014; 12: 473-483.
24. Stoeckle E, Coindre JM, Bonvalot S, et al.,: Prognostic factors in retroperitoneal sarcoma: A multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer 2001; 92: 359-368.
25. Catton CN, O'Sullivan B, Kotwall C, et al.,: Outcome and prognosis in retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys 1994; 29: 1005-1010.
26. Smith MJ, Ridgway PF, Catton CN, et al.,: Combined management of retroperitoneal sarcoma with dose intensification radiotherapy and resection: long-term results of a prospective trial. Radiother Oncol 2014; 110: 165-171.
27. Gronchi A, De Paoli A, Dani C, et al.,: Preoperative chemo-radiation therapy for localised retroperitoneal sarcoma: A phase I-II study from the Italian Sarcoma Group. Eur J Cancer 2014; 50: 784-792.
28. Ploquin NP, Dunscombe PB,: The cost of radiation therapy. Radiother Oncol 2008; 86: 217-223.
29. Jaques DP, Coit DG, Hajdu SI, et al.,: Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum. Ann Surg 1990; 212: 51-59.
30. NCCN. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines(R)): Soft Tissue Sarcoma. 6/11/2014; 2.2014: Available from: http://www.nccn.org/professionals/physician-gls/pdf/sarcoma.pdf.
31. R.P.S. Trans-Atlantic Working Group: Management of primary retroperitoneal sarcoma (RPS) in the adult: A consensus approach from the Trans-Atlantic RPS Working Group. Ann Surg Oncol 2015;22:256-263.
32. Bonvalot, S., Litiere, S., Nzokirantevye, A., et al.,: A phase III randomized study of preoperative radiotherapy plus surgery versus surgery alone for patients with retroperitoneal sarcoma In: http://www.eortc.org/; Available from: Avaliable from: http://www.eortc.be/protoc/details.asp?protocol= 6209 2.
33. Tzeng CW, Fiveash JB, Popple RA, et al.,: Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma. Cancer 2006; 107: 371-379.
34. Tan MC, Brennan MF, Kuk D, et al.,: Histology-based classification predicts pattern of recurrence and improves risk stratification in primary retroperitoneal sarcoma. Ann Surg 2015. Epub ahead of print.
35. Hull, M.A., A. Niemierko, A.B. Haynes, et al.,: Improved Local Control With An Aggressive Strategy Of Preoperative With Or Without Intraoperative Radiation Therapy Combined With Radical Surgical Resection For Retroeritoneal Sarcoma in Connectiv Tissue Oncology Society 2014 Berlin, Germany.